HPV (Human Papillomavirus)-Associated Carcinoma

Explore clinical trials studying HPV (Human Papillomavirus)-Associated Carcinoma. Study availability and eligibility vary by location and protocol.

7 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

HPV (Human Papillomavirus)-Associated Carcinoma trial results

Recruiting

A Phase I/IIa Clinical Trial to Investigate BVAC-E6E7 in Subjects With HPV Positive HNSCC.

NCT06797986

Conditions: Carcinoma, Carcinoma, Squamous Cell, Communicable Diseases, +21 more
Locations: Seoul National Univesity Hospital Seoul, South Korea

Sevrance Hospital Seoul, South Korea

View Trial Details

Recruiting

Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)

NCT07209189

Conditions: Carcinoma, Carcinoma, Squamous Cell, Communicable Diseases, +39 more
Locations: Johns Hopkins Hospital East Baltimore Baltimore, Maryland, United States

View Trial Details

Recruiting

HPV Vaccine, Imiquimod, and Metformin Combination Trial

NCT06686043

Conditions: Cervical Carcinoma, Communicable Diseases, DNA Virus Infections, +32 more
Locations: Baylor St. Luke's Medical Center- Dan L. Duncan Comprehensive Cancer Center Houston, Texas, United States

Harris Health Smith Clinic Houston, Texas, United States

View Trial Details

Not Yet Recruiting

Combining Neo-adjuvant ATR-inhibition With Nodal SBRT for Early-stage Resectable HPV+ OPSCCs

NCT07578467

Conditions: Carcinoma, Carcinoma, Squamous Cell, Communicable Diseases, +21 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED)

NCT07418034

Conditions: Carcinoma, Carcinoma, Squamous Cell, Communicable Diseases, +38 more
Locations: Not specified

View Trial Details

Completed

Immunologic Responses in HPV-Associated Carcinoma for Patients Receiving Chemoradiation

NCT01958515

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +16 more
Locations: The Johns Hopkins SKCCC Baltimore, Maryland, United States

View Trial Details

Active, Not Recruiting

Phase IIIb Clinical Trial of Quadrivalent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) for Age/Immunization Schedule Bridging

NCT06632912

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +12 more
Locations: Shanxian Center for Disease Control and Prevention Heze, Shandong, China

Liaocheng Center for Disease Control and Prevention Liaocheng, Shandong, China

Daiyue District Center for Disease Control and Prevention Tai’an, Shandong, China

View Trial Details

HPV (Human Papillomavirus)-Associated Carcinoma

HPV (Human Papillomavirus)-Associated Carcinoma trial results

A Phase I/IIa Clinical Trial to Investigate BVAC-E6E7 in Subjects With HPV Positive HNSCC.

Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)

HPV Vaccine, Imiquimod, and Metformin Combination Trial

Combining Neo-adjuvant ATR-inhibition With Nodal SBRT for Early-stage Resectable HPV+ OPSCCs

A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED)

Immunologic Responses in HPV-Associated Carcinoma for Patients Receiving Chemoradiation

Phase IIIb Clinical Trial of Quadrivalent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) for Age/Immunization Schedule Bridging

Related conditions